Paul Markovich, president and CEO of Ascendiun, shared his ideas for bringing down healthcare costs, including digital health ...

The industry needs a framework that can translate clinical nuance into a consistent, trusted representation across systems ...

Targeting GLP-1 receptors now has the FDA’s blessing as a way to treat the fatty liver disease called MASH with Novo Nordisk’s weekly injectable drug Wegovy becoming the second approved treatment for ...

These two myths — that networks guarantee access to care and control costs — lead to the third myth: that networks shield ...

Insecurity about transportation can lead to missed appointments and delayed care, and obstacles are more common for cancer ...

AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are ...

The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and ...

Clinical AI startup Abridge held a New York City event to signal it's done being thought of as just an AI scribe. The company announced a Nvidia foundation model partnership, an Eli Lilly investment, ...

CMS Administrator Dr. Mehmet Oz outlined the agency's strategy for making healthcare more affordable during a Tuesday address ...

While the policy changes create new opportunities, they also introduce operational complexity. Here's some important things ...

Healthcare affordability czar Casey Mulligan laid out the economic philosophy guiding the Trump administration's approach to ...

The true promise of AI lies not in autonomy of either the clinician or machine, but in a balanced collaboration that bolsters ...